General Information of the Disease (ID: DIS00114)
Name
Multiple sclerosis
ICD
ICD-11: 8A40
Type(s) of Resistant Mechanism of This Disease
  IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Click to Show/Hide the Full List of Drugs
Teriflunomide
Click to Show/Hide
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms
       Irregularity in Drug Uptake and Drug Efflux (IDUE) Click to Show/Hide
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) [1]
Sensitive Disease Multiple sclerosis [ICD-11: 8A40.0]
Molecule Alteration Expression
Down-regulation
Sensitive Drug Teriflunomide
Experimental Note Revealed Based on the Cell Line Data
Cell Pathway Regulation Cell apoptosis Activation hsa04210
Cell proliferation Inhibition hsa05200
In Vitro Model C57BL/6J cells(Mus musculus (Mouse)) Lymph Homo sapiens (Human) CVCL_5U84
In Vivo Model EAE mice model Mus musculus
Experiment for
Drug Resistance
Annexin V staining assay
Mechanism Description In vitro, intracellular teri concentration in T cells was 2.5-fold higher in abcg2-kO mice than in wt mice. Teri-induced inhibition of T cell proliferation was two fold increased in abcg2-kO cells compared to wt.
Key Molecule: ATP-binding cassette sub-family G2 (ABCG2) [1]
Sensitive Disease Multiple sclerosis [ICD-11: 8A40.0]
Molecule Alteration Expression
Down-regulation
Sensitive Drug Teriflunomide
Experimental Note Revealed Based on the Cell Line Data
Cell Pathway Regulation Cell apoptosis Activation hsa04210
Cell proliferation Inhibition hsa05200
In Vitro Model C57BL/6J cells(Mus musculus (Mouse)) Lymph Homo sapiens (Human) CVCL_5U84
In Vivo Model EAE mice model Mus musculus
Experiment for
Drug Resistance
Annexin V staining assay
Mechanism Description Pharmacological abcg2 inhibition in T cells from wt mice led to an increase of teri-induced apoptosis (Ko143 vs. DMSO: 3.1-fold, p < 0.05; FTC vs. DMSO: 2.8-fold, p > 0.05).
References
Ref 1 Functional relevance of the multi-drug transporter abcg2 on teriflunomide therapy in an animal model of multiple sclerosis. J Neuroinflammation. 2020 Jan 8;17(1):9. doi: 10.1186/s12974-019-1677-z.

If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.